BioCina and NovaCina forge strategic alliance to offer biologics developers integrated drug substance and drug product solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish CDMO, announced a strategic partnership to provide integrated drug substance and drug product solutions for biologics developers.

Healthcare Compliance Professionals Grapple with Mounting Risks

What You Should Know: – A new report from Barnes & Thornburg reveals that healthcare compliance professionals are facing mounting pressure as they navigate a

November 8, 2024

Mettl3 guides CD8 T cells to eliminate infected cells with maximum efficiency

This study is led by Dr. Shuyang Yu (College of Biological Sciences, China Agricultural University), Dr. Jingyu Xu (The Collaborative Innovation Center of Tissue Damage

December 30, 2023

AI Tool Predicts PCI Outcomes; Shellfish Blood Clotter; Persuasive CAC Scan Images

Researchers developed the BMC2 artificial intelligence-based models for predicting death and complications after percutaneous coronary intervention (PCI). (European Heart Journal) A single bolus of recombinant

January 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.